MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors

Tools

Item Type:	Article
Title:	MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors
Creators Name:	Brischwein, K., Schlereth, B., Guller, B., Steiger, C., Wolf, A., Lutterbuese, R., Offner, S., Locher, M., Urbig, T., Raum, T., Kleindienst, P., Wimberger, P., Kimmig, R., Fichtner, I., Kufer, P., Hofmeister, R., da Silva, A.J. and Baeuerle, P.A.
Abstract:	We have developed a novel single-chain Ep-CAM-/CD3-bispecific single-chain antibody construct designated MT110. MT110 redirected unstimulated human peripheral T cells to induce the specific lysis of every Ep-CAM-expressing tumor cell line tested. MT110 induced a costimulation independent polyclonal activation of CD4- and CD8-positive T cells as seen by de novo expression of CD69 and CD25, and secretion of interferon gamma, tumor necrosis factor alpha, and interleukins 2, 4 and 10. CD8-positive T cells made the major contribution to redirected tumor cell lysis by MT110. With a delay, CD4-positive cells could also contribute presumably as consequence of a dramatic upregulation of granzyme B expression. MT110 was highly efficacious in a NOD/SCID mouse model with subcutaneously growing SW480 human colon cancer cells. Five daily doses of 1 μg MT110 on days 0–4 completely prevented tumor outgrowth in all mice treated. The bispecific antibody construct also led to a durable eradication of established tumors in all mice treated with 1 μg doses of MT110 on days 8–12 after tumor inoculation. Finally, MT110 could eradicate patient-derived metastatic ovarian cancer tissue growing under the skin of NOD/SCID mice. MT110 appears as an attractive bispecific antibody candidate for treatment of human Ep-CAM-overexpressing carcinomas.
Keywords:	Ep-CAM, CD3, BiTE, Single-chain antibody, Xenograft model, Tumor, Animals, Mice
Source:	Molecular Immunology
ISSN:	0161-5890
Publisher:	Elsevier Science
Volume:	43
Number:	8
Page Range:	1129-1143
Date:	March 2006
Official Publication:	https://doi.org/10.1016/j.molimm.2005.07.034
PubMed:	View item in PubMed

Repository Staff Only: item control page